Your session is about to expire
← Back to Search
Remote Physical Activity Intervention for Alzheimer's Disease
N/A
Waitlist Available
Research Sponsored by University of Kansas
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Adults with AD - Very mild to moderate dementia
Adults with AD - Ability to communicate verbally
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 18 months
Awards & highlights
Study Summary
This trial is testing whether group video conferencing or enhanced usual care is more effective in increasing moderate physical activity in adults with Alzheimer's disease and their caregivers.
Who is the study for?
This trial is for adults over 55 with mild to moderate Alzheimer's Disease (AD) who can do some physical activity and have internet at home. Their caregivers must be over 18, spend at least 20 hours a week with them, and also be able to exercise. People with serious medical conditions or those already doing regular exercise cannot join.Check my eligibility
What is being tested?
The study compares two ways of increasing physical activity in AD patients and their caregivers: real-time group video workouts versus enhanced usual care without such sessions. It measures how much moderate physical activity they do weekly over an 18-month period.See study design
What are the potential side effects?
Since the interventions involve increased physical activities like walking, potential side effects may include typical exercise-related issues such as muscle soreness or strain, especially if participants are not used to regular activity.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have Alzheimer's with very mild to moderate dementia.
Select...
I can speak and express myself verbally.
Select...
I am 55 years old or older with Alzheimer's disease.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline to 18 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 18 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Moderate Physical Activity
Secondary outcome measures
Activities of Daily Living
Caregiver Burden
Caregiver Functional Fitness
+7 moreOther outcome measures
Body Mass Index
Caregiver support
Energy expenditure of the remote sessions
+5 moreTrial Design
2Treatment groups
Experimental Treatment
Group I: Real-time Group VideoExperimental Treatment1 Intervention
Group II: Enhanced Usual CareExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Enhanced Usual Care
2019
Completed Phase 3
~8530
Find a Location
Who is running the clinical trial?
University of KansasLead Sponsor
147 Previous Clinical Trials
325,762 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,668 Previous Clinical Trials
28,004,965 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have Alzheimer's with very mild to moderate dementia.Adults with Alzheimer's disease who live at home and get help from a caregiver.I can speak and express myself verbally.Criterion: Adults with Alzheimer's disease who are currently exercising more than three times a week for at least 30 minutes each time.I am a caregiver and have had cancer or a serious heart event in the past 5 years.I spend 20 or more hours a week caring for an adult with Alzheimer's.I, as a caregiver, cannot engage in brisk walking.I am 55 years old or older with Alzheimer's disease.I have Alzheimer's disease and am at low risk of falling.I have Alzheimer's Disease and do not want to be randomly assigned to a treatment group.I am a caregiver and do not want to be randomly assigned to a group.I can walk, with or without help, and my primary care doctor agrees I can join physical activities.I am a caregiver and I am 18 years old or older.I don't have major health issues that could interfere with my safety in the study.
Research Study Groups:
This trial has the following groups:- Group 1: Enhanced Usual Care
- Group 2: Real-time Group Video
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is there currently an opportunity to participate in this experiment?
"Affirmative. The clinical trial's presence on clinicaltrials.gov suggests that it is actively seeking participants, which first began being recruited for on July 6th 2020 and was last updated on May 17 2022. A total of 100 individuals need to be sourced from 1 medical centre."
Answered by AI
What is the sample size of this research project?
"Affirmative, the facts found on clinicaltrials.gov demonstrate that this investigation is presently recruiting volunteers. This study was initially posted on June 7th 2020 and has been updated as of May 17th 2022. The trial necessitates 100 participants from 1 distinct medical centre to partake in it."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger